CAMBRIDGE, Mass.--(BUSINESS WIRE)--Epizyme, Inc. (NASDAQ: EPZM), a clinical stage biopharmaceutical company creating novel epigenetic therapeutics for cancer patients, will participate in the Piper Jaffray 27th Annual Healthcare Conference at the Lotte Palace Hotel in New York on Tuesday, December 1 at 1pm ET.
